Cas no 1310384-04-3 ((3-Ethoxypyridin-4-yl)boronic acid)
(3-Ethoxypyridin-4-yl)boronic acid Chemical and Physical Properties
Names and Identifiers
-
- (3-Ethoxypyridin-4-yl)boronic acid
- 3-Ethoxypyridine-4-boronic acid
- 3-ETHOXY-4-PYRIDINYLBORONIC ACID
- 3-Ethoxy-4-pyridinylboronicacid
- 1310384-04-3
- DS-016631
- AB40920
- AKOS006284602
- MFCD07375002
- DTXSID20694506
-
- MDL: MFCD07375002
- Inchi: 1S/C7H10BNO3/c1-2-12-7-5-9-4-3-6(7)8(10)11/h3-5,10-11H,2H2,1H3
- InChI Key: SMKGVAUDYNSOBP-UHFFFAOYSA-N
- SMILES: O(CC)C1C=NC=CC=1B(O)O
Computed Properties
- Exact Mass: 167.07500
- Monoisotopic Mass: 167.0753733g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 12
- Rotatable Bond Count: 3
- Complexity: 134
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 62.6?2
Experimental Properties
- PSA: 62.58000
- LogP: -0.83990
(3-Ethoxypyridin-4-yl)boronic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1643378-5g |
(3-Ethoxypyridin-4-yl)boronic acid |
1310384-04-3 | 98% | 5g |
¥14960.00 | 2024-08-09 |
(3-Ethoxypyridin-4-yl)boronic acid Related Literature
-
Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
-
Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
Additional information on (3-Ethoxypyridin-4-yl)boronic acid
Introduction to (3-Ethoxypyridin-4-yl)boronic Acid (CAS No. 1310384-04-3)
(3-Ethoxypyridin-4-yl)boronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science due to its versatile applications. With the CAS number 1310384-04-3, this compound is recognized for its role as a key intermediate in the synthesis of various bioactive molecules and advanced materials. The boronic acid functional group, particularly in this ethoxypyridine derivative, imparts unique reactivity and binding properties that make it invaluable in modern chemical research.
The< strong>ethoxypyridine moiety in (3-Ethoxypyridin-4-yl)boronic acid contributes to its ability to participate in various organic transformations, including Suzuki-Miyaura cross-coupling reactions, which are widely employed in the construction of complex molecular architectures. This reaction is particularly useful in the pharmaceutical industry for the efficient synthesis of heterocyclic compounds, which are prevalent in many drugs and agrochemicals. The boronic acid component further enhances its utility by allowing for stable complexes with metals, facilitating catalytic processes in organic synthesis.
In recent years, there has been a surge in research focused on the development of novel boronic acid derivatives for therapeutic applications. The< strong>3-Ethoxypyridin-4-ylboronic acid derivative has been explored as a potential building block for drugs targeting various diseases, including cancer and inflammatory disorders. Its structural features enable it to interact with biological targets in a highly specific manner, making it a promising candidate for drug discovery efforts. Additionally, its compatibility with green chemistry principles has led to investigations into its use in sustainable synthetic methodologies.
The compound's reactivity also makes it a valuable tool in materials science, particularly in the development of organic electronic devices. Boronic acids have been shown to exhibit excellent properties when incorporated into polymers and thin films, contributing to advancements in areas such as organic light-emitting diodes (OLEDs) and photovoltaic cells. The< strong>4-pyridyl substituent enhances its solubility and processability, which are critical factors for industrial applications. This has spurred interest in optimizing synthetic routes to produce high-purity (3-Ethoxypyridin-4-yl)boronic acid on an industrial scale.
One of the most compelling aspects of (3-Ethoxypyridin-4-yl)boronic acid is its role in enabling the synthesis of complex molecules through cross-coupling reactions. These reactions are foundational to modern drug discovery, allowing chemists to construct intricate molecular frameworks with precision. The compound's ability to undergo these transformations under mild conditions makes it an attractive choice for both academic research and industrial applications. Furthermore, its stability under various reaction conditions ensures that it can be reliably used in multi-step syntheses without degradation.
The pharmacological potential of (3-Ethoxypyridin-4-yl)boronic acid has been further explored through computational studies and experimental investigations. Researchers have leveraged computational chemistry techniques to predict how this compound might interact with biological targets, providing insights into its potential therapeutic effects. These studies have highlighted its suitability for developing drugs that modulate enzyme activity and signal transduction pathways, which are often implicated in disease states.
In addition to its pharmaceutical applications, (3-Ethoxypyridin-4-yl)boronic acid has found utility in the development of advanced materials. Its ability to form stable complexes with metals has been exploited in catalytic systems designed for organic transformations. These catalytic systems are essential for producing fine chemicals and pharmaceuticals on an industrial scale efficiently. The compound's role as a ligand or intermediate in such systems underscores its importance in modern chemical manufacturing processes.
The synthesis of (3-Ethoxypyridin-4-yl)boronic acid involves carefully controlled conditions to ensure high yield and purity. Advances in synthetic methodologies have enabled the production of this compound with greater ease and efficiency, making it more accessible for research and commercial purposes. Techniques such as transition-metal-catalyzed reactions and flow chemistry have been particularly beneficial in optimizing its synthesis. These innovations have not only improved the scalability of production but also reduced waste generation, aligning with growing environmental concerns.
The future prospects for (3-Ethoxypyridin-4-yl)boronic acid are bright, with ongoing research uncovering new applications and refining existing ones. As our understanding of organic chemistry continues to evolve, so too will the ways in which this compound is utilized. Whether it is through novel drug development or advancements in materials science, (3-Ethoxypyridin-4-yl)boronic acid is poised to remain a cornerstone of modern chemical research for years to come.
1310384-04-3 ((3-Ethoxypyridin-4-yl)boronic acid) Related Products
- 1072952-50-1((3-methoxy-4-pyridyl)boronic acid;hydrate)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)